How GLP-1s are transforming binge eating and big food

A staggering one in eight Americans has tried GLP-1s. We know that, in addition to weight loss, they also help reduce the risk of conditions like type 2 diabetes and cardiovascular disease, and have a role in preventing neurodegenerative diseases like Alzheimer’s or Parkinson’s. But GLP-1 use impacts a common and less discussed condition—binge eating. And the effects are transforming big food.

As a former food entrepreneur, I know more than I wish I did about that profoundly flawed system. I’ve followed it closely for over a decade, and believe that its moment of reckoning is finally here, and not for the reasons I expected.

The genesis of this piece came from conversations with Emilie Faure, founder and CEO of Juniver, an eating disorder company, about the interconnection of binge eating, GLP-1s, and our food system. Here is what we wish everyone knew.